SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000899243-16-021128
Filing Date
2016-05-27
Accepted
2016-05-27 17:15:29
Documents
1
Period of Report
2016-05-26

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 5869
  Complete submission text file 0000899243-16-021128.txt   7142
Mailing Address
Business Address 750 LEXINGTON AVENUE . NEW YORK NY 10022 212-531-5965
KERYX BIOPHARMACEUTICALS INC (Issuer) CIK: 0001114220 (see all company filings)

IRS No.: 134087132 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O INTERCEPT PHARMACEUTICALS, INC. 18 DESBROSSES ST. NEW YORK NY 10013
Business Address
Regan Daniel Paul (Reporting) CIK: 0001571320 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-30929 | Film No.: 161683265